Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trials

By Gidal B.E.   Sheth R.D.   Magnus L.   Herbeuval A.-F.  

Epilepsy Research, Vol. 56, Iss. 2, 2003-10 ,pp. : 121-126

Elsevier

Access to resources Recommend Favorite

Ozagrel for acute ischemic stroke: a meta-analysis of data from randomized controlled trials

By Zhang Jing   Yang Jie   Chang Xueli   Zhang Canfei   Zhou Hongqing   Liu Ming  

Neurological Research, Vol. 34, Iss. 4, 2012-05 ,pp. : 346-353

Maney Publishing

Access to resources Recommend Favorite

Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers

By Levy R.H.   Ragueneau-Majlessi I.   Baltes E.  

Epilepsy Research, Vol. 46, Iss. 2, 2001-08 ,pp. : 93-99

Elsevier

Access to resources Recommend Favorite

Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam

By Trenite D.G.A.K.-N.   Marescaux C.   Stodieck S.   Edelbroek P.M.   Oosting J.  

Epilepsy Research, Vol. 25, Iss. 3, 1996-11 ,pp. : 225-230

Elsevier

Access to resources Recommend Favorite

Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy

By Gower A.J.   Hirsch E.   Boehrer A.   Noyer M.   Marescaux C.  

Epilepsy Research, Vol. 22, Iss. 3, 1995-11 ,pp. : 207-213

Elsevier

Access to resources Recommend Favorite